S 
4.25
+0.71%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue, before interest expense
CN¥1.57bn
FY2016FY2025
Net income
−CN¥1.92bn
FY2016FY2025
Total assets
CN¥21.49bn
FY2016FY2025
Shareholders' equity
CN¥9.81bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | CN¥1.57bn | CN¥1.98bn | CN¥2.42bn | CN¥3.01bn | CN¥4.32bn | CN¥4.38bn | CN¥3.80bn | CN¥2.65bn | CN¥2.33bn | CN¥1.60bn |
| Research and development | CN¥9.0m | CN¥9.8m | CN¥9.4m | CN¥11.1m | CN¥4.9m | CN¥1.3m | CN¥48,742 | — | — | — |
| Operating income | CN¥87.7m | −CN¥652.9m | CN¥353.2m | CN¥733.5m | CN¥1.55bn | CN¥1.89bn | CN¥1.99bn | CN¥1.58bn | CN¥1.17bn | CN¥846.1m |
| Net income | −CN¥1.92bn | −CN¥531.0m | CN¥99.5m | CN¥482.6m | CN¥1.15bn | CN¥1.35bn | CN¥1.32bn | CN¥1.16bn | CN¥829.8m | CN¥620.5m |
| Diluted earnings per share | -1.21 | -0.33 | 0.06 | 0.30 | 0.72 | 0.84 | 0.81 | 0.72 | 0.58 | 0.43 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥21.49bn | CN¥23.85bn | CN¥24.63bn | CN¥26.54bn | CN¥27.05bn | CN¥27.16bn | CN¥26.75bn | CN¥26.13bn | CN¥16.75bn | CN¥15.66bn |
| Cash and short-term investments | — | CN¥1.94bn | CN¥2.34bn | CN¥3.30bn | CN¥3.87bn | CN¥3.65bn | CN¥5.30bn | CN¥4.66bn | CN¥1.95bn | CN¥1.77bn |
| Total liabilities | CN¥11.67bn | CN¥12.07bn | CN¥12.22bn | CN¥14.07bn | CN¥14.66bn | CN¥15.44bn | CN¥15.96bn | CN¥16.44bn | CN¥9.65bn | CN¥9.27bn |
| Debt | CN¥2.56bn | CN¥6.57bn | CN¥6.23bn | CN¥7.88bn | CN¥10.29bn | CN¥10.14bn | CN¥10.72bn | CN¥10.41bn | CN¥5.19bn | CN¥5.10bn |
| Shareholders' equity | CN¥9.81bn | CN¥11.77bn | CN¥12.41bn | CN¥12.46bn | CN¥12.38bn | CN¥11.72bn | CN¥10.78bn | CN¥9.65bn | CN¥7.07bn | CN¥6.38bn |
| Shares outstanding | 1,593m | 1,601m | 1,590m | 1,612m | 1,610m | 1,619m | 1,624m | 1,619m | 1,442m | 1,443m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue, before interest expense | CN¥398.4m | CN¥340.0m | CN¥7.7m | CN¥596.4m | CN¥543.0m | CN¥538.4m | CN¥174.9m | CN¥525.9m |
| Operating income | CN¥27.9m | CN¥53.0m | −CN¥130.0m | CN¥47.6m | CN¥45.5m | CN¥117.2m | −CN¥881.7m | CN¥48.6m |
| Net income | CN¥18.8m | CN¥7.9m | −CN¥2.11bn | CN¥47.4m | CN¥47.5m | CN¥92.8m | −CN¥778.9m | CN¥37.6m |
| Diluted earnings per share | 0.01 | 0.00 | -1.32 | 0.03 | 0.03 | 0.06 | -0.49 | 0.02 |
| Total assets | CN¥21.66bn | CN¥21.60bn | CN¥21.49bn | CN¥23.95bn | CN¥25.50bn | CN¥24.81bn | CN¥23.85bn | CN¥23.68bn |
| Cash and short-term investments | — | — | — | CN¥1.46bn | CN¥3.03bn | CN¥2.04bn | CN¥1.94bn | CN¥2.13bn |
| Debt | CN¥2.61bn | CN¥2.56bn | CN¥2.56bn | CN¥5.23bn | CN¥6.50bn | CN¥6.74bn | CN¥6.08bn | CN¥5.30bn |
| Shareholders' equity | CN¥9.84bn | CN¥9.82bn | CN¥9.81bn | CN¥11.96bn | CN¥11.91bn | CN¥11.87bn | CN¥11.77bn | CN¥12.55bn |
Financial ratios
Data as of 10 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | -145.6% | -18.9% | 27.8% | 36.0% | 40.0% | 47.7% |
| Net margin | -122.5% | -26.9% | 4.1% | 16.0% | 26.7% | 30.9% |
| Return on equity | -19.6% | -4.5% | 0.8% | 3.9% | 9.3% | 11.5% |
| Return on assets | -8.9% | -2.2% | 0.4% | 1.8% | 4.3% | 5.0% |
| Revenue growth | -20.6% | -18.3% | -19.6% | -30.4% | -1.2% | 15.1% |
| Earnings growth | 261.9% | -633.7% | -79.4% | -58.1% | -14.8% | 2.5% |
| Current ratio | 1.15x | 1.24x | 1.35x | 1.40x | 1.36x | 1.58x |
| Debt to equity | 0.26x | 0.52x | 0.46x | 0.58x | 0.78x | 0.81x |
| Equity ratio | 45.7% | 49.4% | 50.4% | 47.0% | 45.8% | 43.1% |
| Interest coverage | -16.87x | -2.78x | 4.59x | 6.20x | 7.70x | 7.81x |
| R&D as a share of sales | 0.6% | 0.5% | 0.4% | 0.4% | 0.1% | 0.0% |
| Buybacks as a share of market value | 0.5% | -0.7% | 1.4% | -0.1% | 0.6% | 0.3% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -19.5% | -18.5% | 1.7% |
| Operating income | -50.7% | -45.9% | -19.5% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -15.9% | 5.8% | 22.4% | 35.1% |
| Net margin | -69.2% | -20.9% | 3.6% | 17.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -4.6 | -15.6 | 81.5 | 18.4 | 9.4 | 9.0 | 11.8 | 11.9 | 19.3 | 28.9 |
| Price to sales | 5.6 | 4.2 | 3.4 | 3.0 | 2.5 | 2.8 | 4.1 | 5.2 | 6.8 | 11.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 11 Jul 2024.
| FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.02 | 0.09 | 0.22 | 0.26 | 0.25 | 0.12 | 0.12 | 0.10 |
- 13-for-10 split · 18 Jun 2015
- 13-for-10 split · 16 Jul 2008
- 1.37-for-1 split · 29 Jan 2008
- 11-for-10 split · 4 Jul 2000
- 11-for-10 split · 12 Jul 1999
- 11-for-10 split · 22 Jun 1998
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.